Home/Filings/4/0001077183-21-000271
4//SEC Filing

Brown Douglas Matthew 4

Accession 0001077183-21-000271

CIK 0001077183other

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 6:02 PM ET

Size

7.5 KB

Accession

0001077183-21-000271

Insider Transaction Report

Form 4
Period: 2021-12-30
Brown Douglas Matthew
Chief Strategy Officer
Transactions
  • Award

    Common Stock

    2021-12-30+30,57242,216 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $53.17Exp: 2028-03-02Common Stock (26,378 underlying)
    26,378
  • Stock Option (Right to Buy)

    Exercise: $28.33Exp: 2027-03-02Common Stock (45,017 underlying)
    45,017
Footnotes (3)
  • [F1]On December 30, 2021, Mr. Brown was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
  • [F2]On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  • [F3]On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Issuer

NEOGENOMICS INC

CIK 0001077183

Entity typeother

Related Parties

1
  • filerCIK 0001849414

Filing Metadata

Form type
4
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 6:02 PM ET
Size
7.5 KB